127 related articles for article (PubMed ID: 10086702)
41. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.
Torizuka T; Tamaki N; Inokuma T; Magata Y; Yonekura Y; Tanaka A; Yamaoka Y; Yamamoto K; Konishi J
J Nucl Med; 1994 Dec; 35(12):1965-9. PubMed ID: 7989978
[TBL] [Abstract][Full Text] [Related]
42. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
[TBL] [Abstract][Full Text] [Related]
43. Validity of 18F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera for detection of myocardial viability.
Hasegawa S; Uehara T; Yamaguchi H; Fujino K; Kusuoka H; Hori M; Nishimura T
J Nucl Med; 1999 Nov; 40(11):1884-92. PubMed ID: 10565785
[TBL] [Abstract][Full Text] [Related]
44. Reproducibility of metabolic measurements in malignant tumors using FDG PET.
Weber WA; Ziegler SI; Thödtmann R; Hanauske AR; Schwaiger M
J Nucl Med; 1999 Nov; 40(11):1771-7. PubMed ID: 10565769
[TBL] [Abstract][Full Text] [Related]
45. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
Walter F; Federman N; Apichairuk W; Nelson S; Phelps ME; Allen-Auerbach M; Walter MA; Czernin J
Pediatr Hematol Oncol; 2011 Oct; 28(7):579-87. PubMed ID: 21936620
[TBL] [Abstract][Full Text] [Related]
46. Localisation of motor areas in brain tumour patients: a comparison of preoperative [18F]FDG-PET and intraoperative cortical electrostimulation.
Schreckenberger M; Spetzger U; Sabri O; Meyer PT; Zeggel T; Zimny M; Gilsbach J; Buell U
Eur J Nucl Med; 2001 Sep; 28(9):1394-403. PubMed ID: 11585300
[TBL] [Abstract][Full Text] [Related]
47. Hyperacute changes in glucose metabolism of brain tumors after stereotactic radiosurgery: a PET study.
Maruyama I; Sadato N; Waki A; Tsuchida T; Yoshida M; Fujibayashi Y; Ishii Y; Kubota T; Yonekura Y
J Nucl Med; 1999 Jul; 40(7):1085-90. PubMed ID: 10405124
[TBL] [Abstract][Full Text] [Related]
48. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM
Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494
[TBL] [Abstract][Full Text] [Related]
49. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.
Laubenbacher C; Saumweber D; Wagner-Manslau C; Kau RJ; Herz M; Avril N; Ziegler S; Kruschke C; Arnold W; Schwaiger M
J Nucl Med; 1995 Oct; 36(10):1747-57. PubMed ID: 7562038
[TBL] [Abstract][Full Text] [Related]
50. Normoglycemic plasma glucose levels affect F-18 FDG uptake in the brain.
Claeys J; Mertens K; D'Asseler Y; Goethals I
Ann Nucl Med; 2010 Jul; 24(6):501-5. PubMed ID: 20237872
[TBL] [Abstract][Full Text] [Related]
51. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors.
Higashi T; Tamaki N; Torizuka T; Nakamoto Y; Sakahara H; Kimura T; Honda T; Inokuma T; Katsushima S; Ohshio G; Imamura M; Konishi J
J Nucl Med; 1998 Oct; 39(10):1727-35. PubMed ID: 9776278
[TBL] [Abstract][Full Text] [Related]
52. Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors.
Marriott CJ; Thorstad W; Akabani G; Brown MT; McLendon RE; Hanson MW; Coleman RE
J Nucl Med; 1998 Aug; 39(8):1376-80. PubMed ID: 9708511
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of fluorinated m-tyrosine analogs as PET imaging agents of dopamine nerve terminals: comparison with 6-fluoroDOPA.
DeJesus OT; Endres CJ; Shelton SE; Nickles RJ; Holden JE
J Nucl Med; 1997 Apr; 38(4):630-6. PubMed ID: 9098215
[TBL] [Abstract][Full Text] [Related]
54. Feasibility of an SUV normalization to 1 hour after the 18F-FDG injection.
Laffon E; Vialard J; Allard M; Ducassou D
C R Biol; 2006 Jul; 329(7):520-6. PubMed ID: 16797458
[TBL] [Abstract][Full Text] [Related]
55. Establishing age-associated normative ranges of the cerebral 18F-FDG uptake ratio in children.
Hua C; Merchant TE; Li X; Li Y; Shulkin BL
J Nucl Med; 2015 Apr; 56(4):575-9. PubMed ID: 25745092
[TBL] [Abstract][Full Text] [Related]
56. [Synthesis and preliminary studies of O-(2-[18F] fluoroethyl)-L-tyrosine as a positron emission tomography imaging agent].
Dang YH; Wang SZ; Cheng X; Zhou Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):370-2. PubMed ID: 12905655
[TBL] [Abstract][Full Text] [Related]
57. PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserin.
van Dyck CH; Tan PZ; Baldwin RM; Amici LA; Garg PK; Ng CK; Soufer R; Charney DS; Innis RB
J Nucl Med; 2000 Feb; 41(2):234-41. PubMed ID: 10688105
[TBL] [Abstract][Full Text] [Related]
58. 6-[18F]fluoro-L-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primates.
Jordan S; Eberling JL; Bankiewicz KS; Rosenberg D; Coxson PG; VanBrocklin HF; O'Neil JP; Emborg ME; Jagust WJ
Brain Res; 1997 Mar; 750(1-2):264-76. PubMed ID: 9098552
[TBL] [Abstract][Full Text] [Related]
59. Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors.
Kaplan AM; Bandy DJ; Manwaring KH; Chen K; Lawson MA; Moss SD; Duncan JD; Wodrich DL; Schnur JA; Reiman EM
J Neurosurg; 1999 Nov; 91(5):797-803. PubMed ID: 10541237
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the accumulation of (11)C-methionine with standardized uptake value in the normal brain.
Uda T; Tsuyuguchi N; Terakawa Y; Takami T; Ohata K
J Nucl Med; 2010 Feb; 51(2):219-22. PubMed ID: 20080891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
